About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT06952855

Observationa Study is a Prospective and Multi-institutional Observational Study.

This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for ...

Lead sponsor: Jeil Pharmaceutical Co., Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Jeil Pharmaceutical Co., Ltd.

The present observational study is designed to check effect and safety for patients who have been prescribed JAQBO for the treatment of erosive gastroesophageal reflux disease.

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. An adult over 19 years of age
•2. A person who voluntarily provides written informed consent

Exclusion Criteria

•1. A pregnant woman or a nursing woman
•2. A person who is deemed unsuitable for the subject of the study

Related studies

Active Not RecruitingPhase 4

Primary carE PPi dEprescRibing Trial

NCT05629143 · Heartburn, Dyspepsia, and more

Not Yet RecruitingNA

Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Reflux Disease With Liver-Stomach Disharmony Syndrome

NCT07518420 · Non-erosive Reflux Disease (NERD)

COMPLETEDPhase 3

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

NCT05890001 · Non-erosive Reflux Disease, Erosive Esophagitis

The Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension on Outpatients With Gastroesophageal Reflux Disease

NCT06889246 · GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency, GERD (Heartburn, Regurgitation, and Dyspepsia) Severity

Evaluation of the Efficacy and Safety of Eolo in Patients With NERD

NCT07041060 · Non-erosive Reflux Disease, Reflux Disease, Gastro-Esophageal, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 13, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment5,536

Start dateNov 2024

Last updatedMay 13, 2025

Condition

Erosive Reflux Disease Heartburn Acid Regurgitation

Locations shown

Goodbreath Medical Center

Seoul, Gyeonggi-do

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 13, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions